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Bile acids have emerged as a new class of signaling molecules that play a role in metaboli sm. Studies in 
mice have shown that the bile acid receptor TGR5 mediates several of these effects but the metaboli c
function of TGR5 in humans is less well establishe d. Here we show that human adipose tissue TGR5
expression is positively correlated to obesity and reduced during diet-induced weight loss. Adipose tissue 
TGR5 expression was also positively correlated to resting metabolic rate. Our study indicates that human 
adipose tissue contributes to the TGR5 mediated metabolic effects of bile acids and plays a role in energy 
expenditure.
 2013 Elsevier Inc. Open access under CC BY license.1. Introduction 
Bile acids are synthesized in the liver and play a central role in 
dietary lipid emulsiﬁcation in the intestine . The majority of the se- 
creted bile acids is taken up by the distal parts of the small intes- 
tine and return to the liver and the gall bladder via the 
enterohepat ic circulation. Beyond their well established function 
in dietary lipid emulsiﬁcation, bile acids are signaling molecules 
with metaboli c effects mediated by speciﬁc receptors. The farne- 
soid X receptor (FXR) is the most studied receptor for bile acids. 
FXR is a nuclear receptor that regulates bile acid synthesis as well 
as lipid and glucose metabolism [1]. The G protein-cou pled recep- 
tor TGR5 (also denoted G protein-coupled bile acid receptor 1 or 
GBPAR1) has also been found to be a functional bile acid receptor 
[2]. In 2006, Watanabe et al. showed that bile acid administration 
augmented energy expenditure in mice [3], and that these effects 
were mediated via the TGR5 and its effects on the thyroid hormone 
activating enzyme iodothyronine deiodinase type II (DIO2) in 
brown adipose tissue (BAT). In addition, they showed that bile acid 
treatment of human skeletal myocytes increased both DIO2 1345 Gothenburg, Sweden. 
.-A. Svensson).
Y license.activity and oxygen consumptio n, indicating that similar mecha- 
nisms are relevant also in humans. More recently, TGR5 activation
has been shown to induce glucagon-like peptide-1 (GLP-1) release 
in mice, indicating a direct role for TGR5 in glucose homeostasi s [4].
Despite these advances in understand ing of TGR5, much less in 
known about TGR5 function in humans and its expression in other 
metaboli cally relevant organs such as adipose tissue. The aim of 
this study was therefore to investiga te the potential role of adipose 
tissue TGR5 in human metabolism. 
2. Materials and methods 
The regional ethics committ ee in Gothenbur g approved these 
studies.
2.1. Sib Pair study 
The swedish obese subjects (SOS) Sib Pair study consists of 154 
nuclear families with BMI discordant sibling pairs (BMI difference 
P10 kg/m 2), resulting in a study population consisting of 732 sub- 
jects [5]. The subjects were extensively phenotyped [5], including 
anthropometr ic measure ments and determination of resting meta- 
bolic rate (RMR) in a ventilated hood [6]. Subcutaneo us adipose 
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analysis. For the current study, complete data from 353 siblings 
and 86 parents were available for the analysis. 
2.2. Very low calorie diet (VLCD) study 
The very low calorie diet (VLCD) study was performed to inves- 
tigate gene expression changes in adipose tissue of obese subjects 
during weight loss induced by caloric restrictio n. Twenty-eight ob- 
ese subjects (20 women and 8 men, age 39.7 ± 12.7 years, BMI 
36.3 ± 3.7 kg/m 2) were treated with VLCD (450 kcal/day) for 
12 weeks [7,8]. Subcutaneo us adipose tissue needle biopsies were 
obtained at the start of the VLCD treatment (day 0) and three times 
during the VLCD treatment (weeks 2, 6, and 12). After 12 weeks of 
VLCD treatment, the mean weight loss was 19%. 
2.3. Perithyroid and perirenal adipose tissue studies 
Perthyroid adipose tissue surgical samples were obtained from 
24 patients undergoing surgery in the thyroid region for malignan- 
cies or endocrine disorders. Clinical characterist ics of the patients 
have been described previously [9]. Perithyroid adipose tissue 
biopsies containing BAT was identiﬁed by expression analysis of 
uncoupling protein 1 (UCP1) and histological analysis. Samples with 
high UCP1 expression was classiﬁed as BAT positive (BAT+, n = 9).
Paired subcutan eous white adipose tissue biopsies from the surgi- 
cal incision area were also obtained from the same nine patients 
(2 men and 7 women, age 47 ± 21 years, BMI 23 ± 2 kg/m 2).
Biopsies of perirenal adipose tissue were obtained from 55 
healthy kidney donors. The perirenal adipose tissue samples were 
screened for UCP1 expression and samples with high UCP1 expres-
sion (samples from 4 men and 6 women) were classiﬁed as BAT po- 
sitive (BAT+) samples. These samples constituted the BAT+ group. 
A control group (n = 10) with low perirenal adipose tissue UCP1
expression (classiﬁed as BAT  samples) was matched to the 
BAT+ group based on sex, age and BMI. The subjects in the BAT+ 
group had an average age of 42 ± 14 years and a BMI of 26 ± 2. 
The subjects in the BAT  group had an average age of 44 ± 9 years 
and a BMI of 26 ± 3. 
2.4. Gene expression analysis 
Total RNA was isolated from adipose tissue using the RNeasy li- 
pid tissue midi kit (Qiagen, Chatsworth , CA) or the phenol–chloro-
form extraction method of Chomczyns ki and Sacchi [10].
Gene expression in adipose tissue from the Sib Pair study and in 
the perithyro id adipose tissue was analyzed study using Human 
Genome U133 plus 2.0 arrays (Affymetrix, Santa Clara, CA). Gene 
expression in the perirenal adipose tissue samples were analyzed 
by (Affymetrix Gene 1.0 ST arrays at the Uppsala Array Platform, 
Uppsala, Sweden). All arrays were analyzed accordin g to the man- 
ufacturer’s instructions. Expression data were analyzed using the 
RMA algorithm (Affymetrix). TGR5 expression was assessed using 
probe sets 1552501_a_at and 8048249 for Human Genome U133 
plus 2.0 and Expression assay Gene 1.0 ST arrays, respectively. 
Adipose tissue total RNA from the VLCD study was reversed 
transcribed using the High Capacity cDNA RT kit (Life Technologies, 
Paisley, UK) according to the manufacturer’s protocol. Reagents for 
real-time PCR analysis of TGR5 (Hs00544894_m1) and low-density 
lipoprotein (LDL) receptor-r elated protein 10 (LPR10)
(Hs00204094_m1) were purchase d from Life Technologies and 
used according to the manufactur er’s instructions. cDNA was used 
for real-time PCR in the Applied Biosystems PRISM 7900HT Se- 
quence Detection System (Life Technologie s) using default cycle 
parameters. A standard curve was plotted for each primer-p robe 
set with a serial dilution of cDNA synthesized from pooled RNA. All samples and standards were analyzed in triplicate and LRP10
gene expression was used as a reference gene [11].
2.5. Gene ontology (GO) enrichment analysis 
GO enrichment analysis was performed using the DAVID 
web–accessible program [12,13] (http://davi d.abcc.ncifcrf.gov ).
Transcrip ts signiﬁcantly correlated with TGR5 expression were 
identiﬁed in the Sib Pair study using Spearman correlation. 
Accounting for multiple testing, a threshold of p < 9.1  107 was
used as a cut off for declaring statistical signiﬁcance (Bonferroni
corr ecti on ). Th is yi eld ed a tot al of 17 55 ne gat iv e and 17 67 pos it iv it y
correlate d transcripts which were included separately in the GO 
enri chme nt analy si s. The an aly si s was li mit ed to the GOT ERM _BP_ 
FAT , GEOTERM_CC_F AT and GEOTERM_MF _FAT options and 
Human Genome U133 Plus 2.0 was used as a background. 
2.6. Statistica l analysis 
Statistica l analyses were performed using the SAS software 
package (v. 9.1.3, SAS Institute Inc., Cary, NC) or and PASW Statis- 
tics (Chicago, IL, USA). Quantitati ve data were transformed towards 
normal distribution using Box–Cox power transformat ions. Outli- 
ers beyond three standard deviations from the trait mean were ex- 
cluded. Correlations between clinical traits and TGR5 expression
were analyzed using the MIXED procedure in SAS. In the linear 
mixed models, we used a ‘‘sandwich estimator’’ of the covariance 
matrix to adjust for non-independe nce among family members. 
This asymptotical ly yields the same parameter as ordinary least 
squares or regression methods while standard errors and, conse- 
quently, hypothesis tests are adjusted for the family relatedne ss. 
Comparis ons in gene expression between BAT and WAT were per- 
formed using Student’s t-test (paired or unpaired as appropriate).
Gene expression during weight loss was analyzed using a one- 
way repeated measures analysis of variance (ANOVA) with Green- 
house–Geisser correction. Comparisons between time points were 
assessed by Bonferroni corrected post-hoc tests. 3. Results 
3.1. TGR5 adipose tissue expression 
Initially, we investiga ted the link between TGR5 adipose tissue 
expression and obesity. Among the Sib Pair families, TGR5 expres-
sion was positively correlated with BMI (r = 0.40, p < 0.0001), inde- 
pendent of age, sex, family membership and generation. In line with 
this ﬁnding, obese subjects treated with VLCD displayed a drastic 
reduction of adipose tissue TGR5 expression determined by a re- 
peated measure s ANOVA (F(1.4, 38) = 38, p < 0.0005; Fig. 1). Com- 
pared to day 0, adipose tissue TGR5 expression was approximately 
half as low during the entire dieting period and post-hoc tests using 
the Bonferroni correction showed that TGR5 levels were reduced 
compare d with day 0 at all subsequent time points measure d
(weeks 2, 6 and 12, p < 0.0005 for each test; Fig. 1).
3.2. Gene ontology enrichment analysis 
To gain insights into functions in adipose tissue that may be re- 
lated to TGR5 expression, Gene ontology enrichment analysis was 
performed using transcripts positivel y or negatively correlated to 
TGR5 expression in subcutan eous adipose tissue in the Sib Pair off- 
spring study. Transcripts negative correlated to TGR5 expression
displayed highly signiﬁcant (adjusted p-values down to 
3  1020) enrichment of several GO terms relating to mitochon- 
dria and ribosome (Table 1). Enrichme nt analysis of transcrip ts 
Table 1
Gene ontology enrichme nt analysis of transcripts correlat ed to TGR5 expression in 
adipose tissue in the Sib Pair study. 
GO term Category Count a Adj p-valueb
Transcripts negatively correlated to TGR5 expression 
Mitochondrion CC 160 3.0E 20 
Mitochondrial part CC 100 8.2E 16 
Intracellular organelle lumen CC 203 4.4E 13 
Organelle lumen CC 205 7.5E 13 
Membrane-enclosed lumen CC 208 9.0E 13 
Translation BP 67 1.6E 11 
Ribosome CC 46 7.1E 11 
Mitochondrial envelope CC 68 6.1E 10 
Organelle inner membrane CC 58 6.3E 10 
Mitochondrial membrane CC 64 1.9E 09 
Mitochondrial lumen CC 46 2.2E 09 
Mitochondrial matrix CC 46 2.2E 09 
Ribosomal subunit CC 32 3.5E 09 
Ribonucleoprotein complex CC 75 4.8E 09 
Mitochondrial inner membrane CC 53 6.1E 09
Transcripts positively correlated to TGR5 expression 
Endoplasmic reticulum CC 135 5.7E 08 
Actin binding MF 54 0.000023 
Cytoskeletal protein binding MF 74 0.000031 
GOLGI apparatus CC 115 0.000033 
Lysosome CC 41 0.00006 
Lytic vacuole CC 41 0.00006 
Endoplasmic reticulum part CC 54 0.00067 
Endoplasmic reticulum lumen CC 21 0.00078 
Vacuole CC 42 0.0014 
Actin cytoskeleton organization BP 39 0.0019 
Cortical cytoskeleton CC 15 0.0019 
Actin ﬁlament-based process BP 41 0.0023 
Cell cortex CC 28 0.0023 
Proteinaceous extracellular matrix CC 48 0.0023 
Extracellular matrix part CC 24 0.0027 
CC = cellular component; BP = biological process; MF = molecular function. 
a Number of correlated transcripts included in the speciﬁc GO term. 
b The table displays the top 15 enriched GO terms based on the adjusted p-value 
(Benjamini).
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Fig. 1. Adipose tissue TGR5 expression during weight loss. Twenty-eight obese 
patients (20 women and 8 men) were treated with a very low caloric diet for 
12 weeks. Subcutaneous adipose tissue biopsies were obtained by needle aspiration 
before the diet (day 0, d0) and after 2, 6 and 12 weeks (w) of diet. TGR5 gene 
expression was analyzed by real-time PCR and normalized to the reference gene 
LRP10. Data is presented as mean ± SEM. ⁄⁄p < 0.0005 compared with d0. 
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of GO terms primarily related to endoplasmatic reticulum/G olgi 
and cytoskeleton function but with less striking p-values (Table 1).
3.3. TGR5 adipose tissue expression and energy expenditure 
Since mitochondr ia play an important role in energy expendi- 
ture and nutrient combustion, we next investigated the relation 
between adipose tissue TGR5 expression and resting metabolic rate 
(RMR) in the Sib Pair study. Unexpectedly, given the negative correlation to mitochond rial genes, TGR5 expression was positively 
correlate d with RMR (r = 0.25, p < 0.0001). In a model including 
age, polynomials of age, sex, lean body mass, generation and family 
membership , the statistical signiﬁcance of this correlation 
persisted.
Brown adipocytes have, in comparison to white adipocytes, 
substanti ally more mitochondr ia. In mice TGR5 has been shown 
to be expressed in brown adipose tissue (BAT) and treatment of 
brown adipocytes with bile acids has been shown to increase 
oxygen expenditur e via TGR5-mediarted activation of DIO2 in
BAT [3]. The expression of TGR5 was therefore investigated in 
two sets of human adipose tissue samples (the perithyriod and 
the perirenal adipose tissue studies) containing islets of BAT 
(BAT+) and compared to expression in white adipose tissue. 
However , no signiﬁcant differenc e in TGR5 expression was 
observed between the BAT containing samples and white adipose 
tissue (Fig. 2A and B).4. Discussion 
In this study, we have characterized the gene expression of 
TGR5 in human adipose tissue. Our main ﬁndings are that TGR5 adi-
pose tissue expression is reduced during weight loss, and that it is 
positivel y correlated with obesity as well as with resting metabolic 
rate.
Our results clearly show that TGR5 expression in adipose tissue 
is regulated in a manner that supports a functional metabolic role 
for TGR5 in adipose tissue. However, our results are not easily rec- 
onciled with the results from the studies of mice treated with bile 
acids [3]. Whereas mice treated with bile acids lose weight, high 
human adipose tissue TGR5 expression is associate d with obesity. 
In addition, the mice studies also show that the mitochondr ia rich 
BAT is a major target organ for the effects of bile acids whereas we 
show a negative correlation of TGR5 to the expression of mitochon- 
drial genes in white adipose tissue. In the light of this, it is not 
unthinkable that the up regulatio n of TGR5 in human adipose tis- 
sue can be viewed as compens atory mechanism to prevent adipose 
tissue growth. However, one has to consider that regulation studies 
in one single organ may not capture the more complex regulation 
of the entire body and that receptor gene or protein expression 
cannot directly be translated to the amount of receptor signaling. 
Expression analysis in human brown fat depots is challenging 
because, in contrast to mouse, human BAT represents a much 
smaller fraction of adipose tissue and is usually not located in dis- 
tinct depots but rather as islets within the white adipose tissue 
[9,14]. Only the expression of a very limited number of genes has 
been investigated in human BAT [9,15,16]. Our analysis of TGR5
expression in human BAT-containi ng adipose tissue samples pro- 
vide no evidence that TGR5 is expressed at higher levels in human 
BAT compared to WAT. This together with the limited amount of 
BAT in humans speaks against that the observed association be- 
tween TGR5 adipose tissue expression and RMR is related to human 
BAT. A more likely scenario is that TGR5 expression in adipose tis- 
sue is co regulated with the TGR5 expression in other metaboli cally 
more active organs such as skeletal muscle or that it is related to 
adipose tissue thermogenesis not involving BAT. The correlation 
between adipose tissue TGR5 expression and RMR is well in line 
with the down-regul ation of TGR5 during the diet intervention, a
situation where RMR is reduced [17]. Interestingl y, the drastic 
reduction of TGR5 expression seen already after 2 weeks preceded 
the maximal weight loss which occurred at week 12 [8]. This indi- 
cates that TGR5 expression in adipose tissue is regulated by energy 
intake or metabolic rate rather than the level of obesity. One study 
has shown that human plasma levels of bile acids are not associ- 
ated with energy metaboli sm [18], indicating that if these systems 
020
40
60
80
100
120
140
160
BAT +
Perirenal AT
BAT –
Perirenal AT
0
2
4
6
8
10
12
s.c.WAT BAT +
Perithyroid AT
TG
R5
 g
en
e e
xp
re
ss
io
n
(D
NA
 
m
ic
ro
ar
ra
y 
sig
na
l v
al
ue
)
TG
R5
 g
en
e e
xp
re
ss
io
n
(D
NA
 
m
ic
ro
ar
ra
y 
sig
na
l v
al
ue
)
n.s. n.s.BA
Fig. 2. TGR5 gene expression in human brown and white adipose tissue. (A) TGR5 expression in BAT containing (BAT+) perithyroid adipose tissue and paired subcutaneous 
white adipose tissue (s.c. WAT, n = 9). (B) TGR5 expression in perirenal adipose tissue containing BAT (BAT+, n = 10) or only containing white adipose tissue (BAT, n = 10).
Data is presented as mean microarray signal ± SEM. n.s. = not signiﬁcant. Note: the different signal values are due to different microarray types. 
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search should probably be directed at the receptor level. 
Obesity represents an independen t cardiovascu lar risk factor 
[19]. In addition to its metabolic role, TGR5 has recently been di- 
rectly implicated in the developmen t of atherosclero sis. Activatio n
of TGR5 in mice was associate d with attenuation of atherosclerosis 
by means of decreased pro-inﬂammatory cytokine production and 
reduced oxidized LDL uptake in macroph ages [20]. These ﬁndings
are of particular interest to our study since adipose tissue is a ma- 
jor source of circulating pro-inﬂammatory cytokines. However , the 
relative contributi on of the adipose tissue TGR5 expression by adi- 
pocytes and macrophages is currently unknown. 
In conclusion, we have shown that adipose tissue expression of 
human TGR5 is reduced during weight loss, and positivel y corre- 
lates to obesity as well as to resting metabolic rate, indicating a
functional metaboli c role for TGR5 in adipose tissue. However, 
more studies are needed to speciﬁcally deﬁne this role. 
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